Toral Zaveri, PhD - Publications

Affiliations: 
 

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Zaveri T, Powell KA, Guthrie KM, Bakke AJ, Ziegler GR, Hayes JE. Qualitative exploration of intrinsic and extrinsic factors that influence acceptability of semisoft vaginal suppositories. Bmc Women's Health. 18: 170. PMID 30342510 DOI: 10.1186/s12905-018-0657-2  0.76
2016 Zaveri T, Running CA, Surapaneni L, Ziegler GR, Hayes JE. Innovative sensory methods to access acceptability of mixed polymer semisoft ovules for microbicide applications. Drug Delivery and Translational Research. PMID 27357703 DOI: 10.1007/s13346-016-0309-8  0.76
2016 Primrose RJ, Zaveri T, Bakke AJ, Ziegler GR, Moskowitz HR, Hayes JE. Drivers of Vaginal Drug Delivery System Acceptability from Internet-Based Conjoint Analysis. Plos One. 11: e0150896. PMID 26999009 DOI: 10.1371/journal.pone.0150896  0.76
2014 Zaveri T, Primrose RJ, Surapaneni L, Ziegler GR, Hayes JE. Firmness Perception Influences Women's Preferences for Vaginal Suppositories. Pharmaceutics. 6: 512-29. PMID 25211123 DOI: 10.3390/pharmaceutics6030512  0.76
2014 Mahan ED, Zaveri T, Ziegler GR, Hayes JE. Relationships between perceptual attributes and rheology in over-the-counter vaginal products: a potential tool for microbicide development. Plos One. 9: e105614. PMID 25188244 DOI: 10.1371/journal.pone.0105614  0.76
2014 Zaveri T, Hayes JE, Ziegler GR. Release of tenofovir from carrageenan-based vaginal suppositories. Pharmaceutics. 6: 366-77. PMID 24999606 DOI: 10.3390/pharmaceutics6030366  0.76
2014 Zaveri TD, Lewis JS, Dolgova NV, Clare-Salzler MJ, Keselowsky BG. Integrin-directed modulation of macrophage responses to biomaterials. Biomaterials. 35: 3504-15. PMID 24462356 DOI: 10.1016/j.biomaterials.2014.01.007  0.76
2013 Li B, Zaveri T, Ziegler GR, Hayes JE. User preferences in a carrageenan-based vaginal drug delivery system. Plos One. 8: e54975. PMID 23358688 DOI: 10.1371/journal.pone.0054975  0.76
2013 Li B, Zaveri T, Ziegler GR, Hayes JE. Shape of vaginal suppositories affects willingness-to-try and preference. Antiviral Research. 97: 280-4. PMID 23276592 DOI: 10.1016/j.antiviral.2012.12.024  0.76
2012 Jansson T, Clare-Salzler ZJ, Zaveri TD, Mehta S, Dolgova NV, Chu BH, Ren F, Keselowsky BG. Antibacterial effects of zinc oxide nanorod surfaces. Journal of Nanoscience and Nanotechnology. 12: 7132-8. PMID 23035444 DOI: 10.1166/jnn.2012.6587  0.76
2012 Lewis JS, Zaveri TD, Crooks CP, Keselowsky BG. Microparticle surface modifications targeting dendritic cells for non-activating applications. Biomaterials. 33: 7221-32. PMID 22796161 DOI: 10.1016/j.biomaterials.2012.06.049  0.76
2010 Zaveri TD, Dolgova NV, Chu BH, Lee J, Wong J, Lele TP, Ren F, Keselowsky BG. Contributions of surface topography and cytotoxicity to the macrophage response to zinc oxide nanorods. Biomaterials. 31: 2999-3007. PMID 20074795 DOI: 10.1016/j.biomaterials.2009.12.055  0.76
2009 Zaveri T, Dolgova N, Chu BH, Lee J, Lele T, Ren F, Keselowsky BG. Macrophage response to zinc oxide nanorod surfaces -topography and toxicity Ifmbe Proceedings. 24: 119-120. DOI: 10.1007/978-3-642-01697-4_41  0.76
2008 Zaveri T, Dolgova N, Clare-Salzler M, Keselowsky BG. Modulating macrophage response to wear particles to mitigate peri-implant osteolysis 8th World Biomaterials Congress 2008. 1: 435.  0.76
2007 Dunn AC, Zaveri TD, Keselowsky BG, Sawyer WG. Macroscopic friction coefficient measurements on living endothelial cells Tribology Letters. 27: 233-238. DOI: 10.1007/s11249-007-9230-0  0.76
Show low-probability matches.